The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Pathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Krag, D. N., Anderson, S. J., Julian, T. B., Brown, A. M., Harlow, S. P., Costantino, J. P., Ashikaga, T., Weaver, D. L., Mamounas, E. P., Jalovec, L. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70207-2 · Cited by 1,920
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789 · cited 1×
“Primary systemic therapy is indicated for locally advanced breast cancer (stages IIIA–B) including inflammatory breast cancer [III, B] and for large operable tumors for reducing tumor size in order possibly to perform BCS [I, A] [73] and to assess responsiveness to systemic therapy in clinical trials [89].”
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Hughes, K. S., Schnaper, L. A., Berry, D., Cirrincione, C., McCormick, B., Shank, B., Wheeler, J., Champion, L. A., Smith, T. J., Smith, B. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040587 · Cited by 1,078
Fisher, B., Dignam, J., Wolmark, N., Wickerham, D. L., Fisher, E. R., Mamounas, E., Smith, R., Begovic, M., Dimitrov, N. V., Margolese, R. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05036-9 · Cited by 1,040
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., Helbich, T., Heywang-Köbrunner, S. H., Kaiser, W. A., Kerin, M. J., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.015 · Cited by 992
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 919
Coombes, R., Kilburn, L., Snowdon, C., Paridaens, R., Coleman, R., Jones, S., Jassem, J., Van de Velde, C., Delozier, T., Alvarez, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60200-1 · Cited by 907
Annual hazard rates of recurrence for breast cancer after primary therapy.
Saphner, T., Tormey, D. C., & Gray, R. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2738 · Cited by 830
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Dowsett, M., Cuzick, J., Ingle, J., Coates, A., Forbes, J., Bliss, J., Buyse, M., Baum, M., Buzdar, A., Colleoni, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1274 · Cited by 813
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Smith, I. E., Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Blohmer, J.-U., Ashley, S. E., Francis, S., Boeddinghaus, I., & Walsh, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.005 · Cited by 774
Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., Alvarado, M., Flyger, H. L., Massarut, S., Eiermann, W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60837-9 · Cited by 772
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Eiermann, W., Paepke, S., Appfelstaedt, J., Llombart-Cussac, A., Eremin, J., Vinholes, J., Mauriac, L., Ellis, M., Lassus, M., Chaudri-Ross, H. A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013128213451 · Cited by 713
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Polgár, C., Limbergen, E. V., Pötter, R., Kovács, G., Polo, A., Lyczek, J., Hildebrandt, G., Niehoff, P., Guinot, J. L., Guedea, F., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.014 · Cited by 633
Weight Loss in Breast Cancer Patient Management
Chlebowski, R. T., Aiello, E. J., & McTiernan, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1128 · Cited by 623
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Jones, S., Holmes, F. A., O'Shaughnessy, J., Blum, J. L., Vukelja, S. J., McIntyre, K. J., Pippen, J. E., Bordelon, J. H., Kirby, R. L., Sandbach, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.4028 · Cited by 588
Weight lifting in women with breast-cancer-related lymphedema
Schmitz, K. H., Ahmed, R. L., Troxel, A., Cheville, A., Smith, R., Lewis-Grant, L., Bryan, C. J., Williams-Smith, C. T., & Greene, Q. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810118 · Cited by 578
Roché, H., Fumoleau, P., Spielmann, M., Canon, J.-L., Delozier, T., Serin, D., Symann, M., Kerbrat, P., Soulié, P., Eichler, F., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3916 · Cited by 577
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S. K., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 567
Cuzick, J., Sestak, I., Pinder, S. E., Ellis, I. O., Forsyth, S., Bundred, N. J., Forbes, J. F., Bishop, H., Fentiman, I. S., & George, W. D. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70266-7 · Cited by 567
Irwin, M. L., Smith, A. W., McTiernan, A., Ballard-Barbash, R., Cronin, K., Gilliland, F. D., Baumgartner, R. N., Baumgartner, K. B., & Bernstein, L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9822 · Cited by 562
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810818 · Cited by 496
Mutrie, N., Campbell, A. M., Whyte, F., McConnachie, A., Emslie, C., Lee, L., Kearney, N., Walker, A., & Ritchie, D. (2007) · BMJ · doi:10.1136/bmj.39094.648553.ae · Cited by 440
Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M. (2010) · BMJ · doi:10.1136/bmj.c3620 · Cited by 412
Weight Lifting for Women at Risk for Breast Cancer–Related Lymphedema: A Randomized Trial
Schmitz, K. H., Ahmed, R. L., Troxel, A. B., Cheville, A., Lewis-Grant, L., Smith, R., Bryan, C. J., Williams-Smith, C. T., & Chittams, J. (2010) · JAMA · doi:10.1001/jama.2010.1837 · Cited by 410
Exercise for women receiving adjuvant therapy for breast cancer
Markes, M., Brockow, T., & Resch, K.-L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005001.pub2 · Cited by 367
Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
Swain, S. M., Jeong, J.-H., Geyer, C. E., Costantino, J. P., Pajon, E. R., Fehrenbacher, L., Atkins, J. N., Polikoff, J., Vogel, V. G., Erban, J. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909638 · Cited by 338
Gnant, M. F. X., Mlineritsch, B., Luschin-Ebengreuth, G., Grampp, S., Kaessmann, H., Schmid, M., Menzel, C., Piswanger-Soelkner, J. C., Galid, A., Mittlboeck, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7102 · Cited by 331
Eidtmann, H., de Boer, R., Bundred, N., Llombart-Cussac, A., Davidson, N., Neven, P., von Minckwitz, G., Miller, J., Schenk, N., & Coleman, R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq217 · Cited by 281
von Minckwitz, G., Untch, M., Nüesch, E., Loibl, S., Kaufmann, M., Kümmel, S., Fasching, P. A., Eiermann, W., Blohmer, J.-U., Costa, S. D., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1228-x · Cited by 280
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2008) · The Lancet · doi:10.1016/s0140-6736(08)60069-0 · Cited by 279
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
Knauer, M., Mook, S., Rutgers, E. J. T., Bender, R. A., Hauptmann, M., van de Vijver, M. J., Koornstra, R. H. T., Bueno-de-Mesquita, J. M., Linn, S. C., & van ’t Veer, L. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0814-2 · Cited by 267
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
Bonadonna, G., Moliterni, A., Zambetti, M., Daidone, M. G., Pilotti, S., Gianni, L., & Valagussa, P. (2005) · BMJ · doi:10.1136/bmj.38314.622095.8f · Cited by 252
By the French Adjuvant Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.602 · Cited by 252
(2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0783 · Cited by 244
Reid, D. M., Doughty, J., Eastell, R., Heys, S. D., Howell, A., McCloskey, E. V., Powles, T., Selby, P., & Coleman, R. E. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.007 · Cited by 228
Davidson, N. E., O'Neill, A. M., Vukov, A. M., Osborne, C. K., Martino, S., White, D. R., & Abeloff, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.551 · Cited by 227
Gianni, L., Baselga, J., Eiermann, W., Porta, V. G., Semiglazov, V., Lluch, A., Zambetti, M., Sabadell, D., Raab, G., Cussac, A. L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2567 · Cited by 220
Levine, M. N., Pritchard, K. I., Bramwell, V. H. C., Shepherd, L. E., Tu, D., & Paul, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.423 · Cited by 220
Bundred, N. J., Campbell, I. D., Davidson, N., DeBoer, R. H., Eidtmann, H., Monnier, A., Neven, P., von Minckwitz, G., Miller, J. C., Schenk, N. L., et al. (2008) · Cancer · doi:10.1002/cncr.23259 · Cited by 218
Surgical guidelines for the management of breast cancer
Association of Breast Surgery at (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2009.01.008 · Cited by 212
Jatoi, I., Chen, B. E., Anderson, W. F., & Rosenberg, P. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2106 · Cited by 211
Risk Factors for the Incidence of Breast Cancer: Do They Affect Survival From the Disease?
Barnett, G. C., Shah, M., Redman, K., Easton, D. F., Ponder, B. A. J., & Pharoah, P. D. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3168 · Cited by 207
Poole, C. J., Earl, H. M., Hiller, L., Dunn, J. A., Bathers, S., Grieve, R. J., Spooner, D. A., Agrawal, R. K., Fernando, I. N., Brunt, A. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052084 · Cited by 190
Buzzoni, R., Bonadonna, G., Valagussa, P., & Zambetti, M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.12.2134 · Cited by 162
Francis, P. A., Crown, J. P., Leo, A. D., Buyse, M. E., Balil, A., Andersson, M., Nordenskjöld, B. A., Láng, I., Jakesz, R., Vorobiof, D., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm287 · Cited by 156
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
Sideras, K., Ingle, J. N., Ames, M. M., Loprinzi, C. L., Mrazek, D. P., Black, J. L., Weinshilboum, R. M., Hawse, J. R., Spelsberg, T. C., & Goetz, M. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8931 · Cited by 155
Hershman, D. L., McMahon, D. J., Crew, K. D., Cremers, S., Irani, D., Cucchiara, G., Brafman, L., & Shane, E. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4707 · Cited by 153
Burnell, M. J., Levine, M. N., Chapman, J. W., Bramwell, V. H. C., Gelmon, K. A., Walley, B. A., Vandenberg, T. A., Chalchal, H. I., Albain, K. S., Perez, E. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1077 · Cited by 151
Colleoni, M. A., Giobbie‐Hurder, A., Regan, M. M., Thurlimann, B. J. K., Mouridsen, H. T., Mauriac, L., Forbes, J., Paridaens, R., Láng, I., Smith, I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6455 · Cited by 151
Li, C. I., Daling, J. R., Porter, P. L., Tang, M.-T. C., & Malone, K. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1597 · Cited by 145
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M. M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4482 · Cited by 140
Nicholson, R. M., Leinster, S., & Sassoon, E. M. (2007) · The Breast · doi:10.1016/j.breast.2007.01.009 · Cited by 138
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis
Gondos, Á., Bray, F., Hakulinen, T. R., & Brenner, H. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn639 · Cited by 110
Reading the prognosis of the individual with breast cancer
Blamey, R. W., Pinder, S. E., Ball, G., Ellis, I. O., Elston, C. W., Mitchell, M. J., & Haybittle, J. L. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.003 · Cited by 57
Leyland-Jones, B., Regan, M. M., Bouzyk, M., Kammler, R., Tang, W., Pagani, O., Maibach, R., Dell’Orto, P., Thurlimann, B. J. K., Price, K. N., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-s1-8 · Cited by 53
Breast conservation and negative margins: how much is enough?
Morrow, M. (2009) · The Breast · doi:10.1016/s0960-9776(09)70279-6 · Cited by 50
Rae, J., Drury, S., Hayes, D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-s1-7 · Cited by 46
Isern, A. E., Loman, N., Malina, J., Olsson, H. L., & Ringberg, A. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.03.002 · Cited by 37
Cited by
An overview of triple-negative breast cancer
Kumar, P., & Aggarwal, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3859-y · Cited by 771
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Coombes, R. C., Page, K., Salari, R., Hastings, R. K., Armstrong, A., Ahmed, S., Ali, S., Cleator, S., Kenny, L., Stebbing, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3663 · Cited by 510
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
Self-citationSinn, H.-P., & Kreipe, H. (2013) · Breast Care · doi:10.1159/000350774 · Cited by 403
Ismael, G., Hegg, R., Muehlbauer, S., Heinzmann, D., Lum, B., Kim, S.-B., Pienkowski, T., Lichinitser, M., Semiglazov, V., Melichar, B., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70329-7 · Cited by 351
Metadata
- Authors
- Aebi, S., Davidson, T., Gruber, G., & Cardoso, F.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 22
- Pages
- vi12-vi24
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4243674373
- Cited by
- 256
- References
- 82
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.